Discovery of more aspirin benefits being slowed by the drug's success

07/9/2004 | Guardian (London), The

The discovery of aspirin's many benefits, from treating cancer to dementia, is the result of decades of clinical studies and hard scientific investigation, but future discoveries are in doubt because of obstacles to further research. One problem is that researchers are reluctant to give a placebo in an aspirin trial for fear a patient might succumb to a disease, while fewer people are willing to take part in trials if they might only get a placebo.

View Full Article in:

Guardian (London), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ